AI summary
A controversial US-backed hepatitis B vaccine trial in Guinea-Bissau was halted after global backlash and a lack of necessary governmental approval.
AI-generated summary. Check the original reporting for context and accuracy.
Controversial US-backed vaccine trial in African newborns halted
Source excerpt
This is the available feed excerpt, which may be shortened or in the publisher’s original language.
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday.It is “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.” Continue reading...
About priority
An automated sorting aid based on source trust, keywords, and entities, on a scale of 1–12. High: 9–12; medium: 6–8; low: 1–5. It does not measure urgency, verify reporting, or indicate editorial endorsement.